Matches in SemOpenAlex for { <https://semopenalex.org/work/W575812144> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W575812144 endingPage "86" @default.
- W575812144 startingPage "84" @default.
- W575812144 abstract "Objective To compare the inhibitory effects to mice ascitic hepatoma (HepA) among hematoxylin,mitomycin,cisplatin,hydroxycamptothecine and other medicine in celiac chemotherapeutic route,probing into the credibility of hematoxylin in celiac chemotherapy.Methods Mice ascitic HepA model was set up by celiac inoculation of HepA strains.24 h after the inoculation,intraperitoneal administration was done,then raising the mice as routine.Their body weights were measured regularly,living quality observed,mean survival times compared among these groups.Having repeated the above experiment three tines,T/C values obtained in the three experiments were compared one another.Results The awerage survival time of mice of control group (inoculated but no medicine used) was 15.99-16.33 d; that of hematoxylin group was 36.35-39.81 d; that of mitomycin gro.up was 35.77-40.06 d; that of hydroxycamptothecine survived 20.79-38.47 d; and that of cisplatin group was 32.98-41.89 d.A comprehensive comparison showed that mitomycin group and hematoxylin group had better effects.Conclusion Hematoxylin in celiac chemotherapy has an outstanding effect to the mice's transplanted HepA,no significant difference with mitomycin.However,hydroxycamptothecine and cisplatin are not good enough.Key words: Hematoxylin; Mitomycin; Celiac cbemotherapy; Mice; HepA" @default.
- W575812144 created "2016-06-24" @default.
- W575812144 creator A5003590887 @default.
- W575812144 creator A5035349992 @default.
- W575812144 creator A5055477924 @default.
- W575812144 creator A5061023059 @default.
- W575812144 creator A5061133165 @default.
- W575812144 creator A5081384420 @default.
- W575812144 date "2009-02-28" @default.
- W575812144 modified "2023-10-01" @default.
- W575812144 title "Comparison on hematoxylin, cisplatin, hydroxycamptothecine and ather medicine in celiac ehemotherapy for mice hepatoma (HepA) model and their inhibitory effect." @default.
- W575812144 doi "https://doi.org/10.3760/cma.j.issn.1006-9801.2009.02.004" @default.
- W575812144 hasPublicationYear "2009" @default.
- W575812144 type Work @default.
- W575812144 sameAs 575812144 @default.
- W575812144 citedByCount "0" @default.
- W575812144 crossrefType "journal-article" @default.
- W575812144 hasAuthorship W575812144A5003590887 @default.
- W575812144 hasAuthorship W575812144A5035349992 @default.
- W575812144 hasAuthorship W575812144A5055477924 @default.
- W575812144 hasAuthorship W575812144A5061023059 @default.
- W575812144 hasAuthorship W575812144A5061133165 @default.
- W575812144 hasAuthorship W575812144A5081384420 @default.
- W575812144 hasConcept C106131492 @default.
- W575812144 hasConcept C125473707 @default.
- W575812144 hasConcept C126322002 @default.
- W575812144 hasConcept C141071460 @default.
- W575812144 hasConcept C142724271 @default.
- W575812144 hasConcept C26140837 @default.
- W575812144 hasConcept C2776694085 @default.
- W575812144 hasConcept C2778239845 @default.
- W575812144 hasConcept C2779338040 @default.
- W575812144 hasConcept C2780159080 @default.
- W575812144 hasConcept C31972630 @default.
- W575812144 hasConcept C41008148 @default.
- W575812144 hasConcept C71924100 @default.
- W575812144 hasConcept C74864618 @default.
- W575812144 hasConceptScore W575812144C106131492 @default.
- W575812144 hasConceptScore W575812144C125473707 @default.
- W575812144 hasConceptScore W575812144C126322002 @default.
- W575812144 hasConceptScore W575812144C141071460 @default.
- W575812144 hasConceptScore W575812144C142724271 @default.
- W575812144 hasConceptScore W575812144C26140837 @default.
- W575812144 hasConceptScore W575812144C2776694085 @default.
- W575812144 hasConceptScore W575812144C2778239845 @default.
- W575812144 hasConceptScore W575812144C2779338040 @default.
- W575812144 hasConceptScore W575812144C2780159080 @default.
- W575812144 hasConceptScore W575812144C31972630 @default.
- W575812144 hasConceptScore W575812144C41008148 @default.
- W575812144 hasConceptScore W575812144C71924100 @default.
- W575812144 hasConceptScore W575812144C74864618 @default.
- W575812144 hasIssue "2" @default.
- W575812144 hasLocation W5758121441 @default.
- W575812144 hasOpenAccess W575812144 @default.
- W575812144 hasPrimaryLocation W5758121441 @default.
- W575812144 hasRelatedWork W1512464017 @default.
- W575812144 hasRelatedWork W1540363171 @default.
- W575812144 hasRelatedWork W2020576896 @default.
- W575812144 hasRelatedWork W230772225 @default.
- W575812144 hasRelatedWork W2350263136 @default.
- W575812144 hasRelatedWork W2352010623 @default.
- W575812144 hasRelatedWork W2370155092 @default.
- W575812144 hasRelatedWork W2375639339 @default.
- W575812144 hasRelatedWork W2377009989 @default.
- W575812144 hasRelatedWork W2381656044 @default.
- W575812144 hasRelatedWork W2383061302 @default.
- W575812144 hasRelatedWork W2386081832 @default.
- W575812144 hasRelatedWork W2387415323 @default.
- W575812144 hasRelatedWork W2411257801 @default.
- W575812144 hasRelatedWork W2413043829 @default.
- W575812144 hasRelatedWork W2415104013 @default.
- W575812144 hasRelatedWork W2415918576 @default.
- W575812144 hasRelatedWork W2471262105 @default.
- W575812144 hasRelatedWork W3032785538 @default.
- W575812144 hasRelatedWork W2186848199 @default.
- W575812144 hasVolume "21" @default.
- W575812144 isParatext "false" @default.
- W575812144 isRetracted "false" @default.
- W575812144 magId "575812144" @default.
- W575812144 workType "article" @default.